tdgeek:
not so grey for the drug designers. the dose size, whether its one or two, etc etc etc isn't a guess. Is it 100% known and documented? No. For the many weeks these vaccines have been discussed, new ones are created, its has built towards active vaccinations. Now its ok to dilute the dosage as a worthwhile tradeoff. Ok.
Given that as you say no one knows everything yet, so we cant make the correct decision. Why risk diluting the dose? It may well be that the full dose is not enough, so we make it worse by guessing that its ok to halve it. Do you design something and test it, then dilute it? As I said its like most lockdowns. If its called a lockdown, thats good enough, but as we know, the diluted lockdowns many countries had did more harm than good
I'm a research engineer. I design awesome stuff and then make it deliberately crappier to meet some arbitrary specification for a living.
The tradeoff that is being discussed is (in essence) do we vaccinate 1 million people to a 0.95 effectiveness, or do we vaccinate 2 million people to a 0.9 effectiveness to buy time. That may be done by cutting the dose OR just lengthening the time between doses.
The input data required to make that call even semi-competently is enormous, but it can be done.